Table 2.
Clinical and laboratory details of +ICH cases
| No. | Mother | Newborn | anti-αvβ3 (OD) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| gravida/para | antibody specificity | week of gestation | sex | platelet nadir (G/l) | ICH | bleeding localization | other bleeding symptoms | ||
| 1 | I/I | HPA-1a | 38+0 | F | 18 | yes | parenchymal, left fronto-parietal lobe | no | 0.674 |
| 2 | I/I | HPA-1a | 38+6 | F | 21 | yes | parenchymal, left side | P, H | 0.488 |
| 3 | II/II | HPA-1a | 40+3 | M | 3 | yes | NR | P, H | 0.664 |
| 4 | VI/V | HPA-1a | 39+0 | M | 5 | yes | parenchymal, left temporal lobe | P | 0.800 |
| 5 | II/II | HPA-1a | 37+6 | F | 5 | yes | subependymal, left side | P, H | 0.777 |
| 6 | II/I | HPA-1a | 40+0 | M | 30 | yes | left thalamus and internal capsule | P | 0.402 |
| 7 | I/I | HPA-1a | 39+6 | M | 10 | yes | periventricular, right side, and plexus cyst | P, H | 0.999 |
| 8 | IV/II | HPA-1a | 34+4 | NR | 5 | yes | intra- and periventricular | 0.549 | |
| 9 | III/II | HPA-1a | 36+6 | F | 45 | yes | parenchymal, right temporal lobe, grade IV | P | 0.685 |
| 10 | III/III | HPA-1a | 41+2 | F | 7 | yes | parenchymal, left parieto-occipital lobe | P,H | 0.721 |
| 11 | II/I | HPA-1a | 36+0 | F | 14 | yes | parenchymal, left parieto-temporal lobe | P | 0.689 |
| 12 | II/I | HPA-1a | 38+0 | M | 17 | yes | parenchymal, right temporal lobe | H, U | 0.780 |
| 13 | II/II | HPA-1a | 34+5 | M | 24 | yes | intraventricular | P | 0.548 |
| 14 | NR | HPA-1a | NR | F | 12 | yes | parenchymal | no | 0.369 |
| 15 | III/I | HPA-1a | 41+3 | F | 12 | yes | parenchymal, left parieto-occipital lobe and right frontal lobe | P, H | 0.995 |
| 16 | NR | HPA-1a | 39+0 | M | 2 | yes | parenchymal | P, H | 0.565 |
| 17 | I/I | HPA-1a | 38+0 | M | 10 | yes | porencephalic cyst, right frontal lobe | P, H | 0.686 |
| 18 | II/I | HPA-1a | NR | M | 20 | yes | parenchymal, left and right hemisphere | no | 0.206 |
NR = not reported; P = petechiae; H = hematoma; U = hematuria; IU = in utero